Does Rallies track congressional trades in RMD?

Yes. Rallies tracks politician and congressional stock disclosures for RMD, including reported purchases, sales, dates, owners, and trade amounts when available.

Is RMD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RMD. It does not provide personalized investment advice.

RMD (ResMed Inc.) Stock Analysis - Politician Trades

ResMed Inc. (RMD) is a publicly traded Healthcare sector company. As of May 21, 2026, RMD trades at $210.64 with a market cap of $29.61B and a P/E ratio of 20.24. RMD moved +1.11% today. Year to date, RMD is -14.47%; over the trailing twelve months it is -15.43%. Its 52-week range spans $198.61 to $293.81. Analyst consensus is buy with an average price target of $264.56. Rallies surfaces RMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded RMD stock?

Recent politician trading activity in RMD includes disclosures from Kelly Louise Morrison, Kelly Morrison, Ro Khanna, Tommy Tuberville, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

RMD Key Metrics

Key financial metrics for RMD
Metric	Value
Price	$210.64
Market Cap	$29.61B
P/E Ratio	20.24
EPS	$10.41
Dividend Yield	0.60%
52-Week High	$293.81
52-Week Low	$198.61
Volume	152
Avg Volume	0
Revenue (TTM)	$5.54B
Net Income	$1.52B
Gross Margin	61.59%

Congressional Trades in RMD

Kelly Louise Morrison sale RMD on Jun 4, 2025 (amount: $15.00K).
Kelly Morrison sale RMD on Apr 28, 2025 (amount: $15.00K).
Ro Khanna purchase RMD on Nov 15, 2024 (amount: $15.00K).
Tommy Tuberville sale (full) RMD on May 3, 2024 (amount: $15.00K) for Joint.
Tommy Tuberville purchase RMD on Oct 17, 2023 (amount: $15.00K) for Joint.

Latest RMD News

ResMed slides after Q3 beat as investors eye costs and post-earnings positioning — May 1, 2026
ResMed’s AirTouch N30i Mask Gains 6% Compliance Lift, Noctrix Acquisition Raises Margins — May 1, 2026
ResMed slides 3% after Q3 earnings: beat on sales, but costs and outlook worry — Apr 30, 2026
ResMed CFO Brett Sandercock Retires After 20 Years; Aaron Bloomer Appointed — Apr 30, 2026
ResMed’s $255 Price Target Signals 11.7% Upside as Insiders Sell $1.5M Shares — Apr 13, 2026

Recent RMD Insider Trades

Farrell Michael J. sold 4.99K (~$1.04M) on May 7, 2026.
Farrell Michael J. sold 4.99K (~$1.13M) on Apr 7, 2026.
Sandercock Brett sold 1.00K (~$224.31K) on Apr 1, 2026.

RMD Analyst Consensus

13 analysts cover RMD: 0 strong buy, 8 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $264.56.

Common questions about RMD

Which politicians traded RMD stock?: Recent politician trading activity in RMD includes disclosures from Kelly Louise Morrison, Kelly Morrison, Ro Khanna, Tommy Tuberville, and Tommy Tuberville. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in RMD?: Yes. Rallies tracks politician and congressional stock disclosures for RMD, including reported purchases, sales, dates, owners, and trade amounts when available.
Is RMD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RMD. It does not provide personalized investment advice.